scispace - formally typeset
P

Patrick Aloy

Researcher at Catalan Institution for Research and Advanced Studies

Publications -  164
Citations -  14554

Patrick Aloy is an academic researcher from Catalan Institution for Research and Advanced Studies. The author has contributed to research in topics: Interactome & Gene. The author has an hindex of 51, co-authored 155 publications receiving 12770 citations. Previous affiliations of Patrick Aloy include Barcelona Supercomputing Center & Utrecht University.

Papers
More filters
Journal ArticleDOI

A proteome-scale map of the human interactome network

Thomas Rolland, +80 more
- 20 Nov 2014 - 
TL;DR: The map uncovers significant interconnectivity between known and candidate cancer gene products, providing unbiased evidence for an expanded functional cancer landscape, while demonstrating how high-quality interactome models will help "connect the dots" of the genomic revolution.
Journal ArticleDOI

A reference map of the human binary protein interactome

Katja Luck, +94 more
- 08 Apr 2020 - 
TL;DR: The utility of HuRI is demonstrated in identifying the specific subcellular roles of protein–protein interactions and in identifying potential molecular mechanisms that might underlie tissue-specific phenotypes of Mendelian diseases.
Journal ArticleDOI

Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing

TL;DR: This work cloned full-length open reading frames of alternatively spliced transcripts for a large number of human genes and used protein-protein interaction profiling to functionally compare hundreds of protein isoform pairs, revealing a widespread expansion of protein interaction capabilities through alternative splicing and suggesting that many alternative "isoforms" are functionally divergent (i.e., "functional alloforms").
Journal ArticleDOI

Interactome3D: adding structural details to protein networks

TL;DR: The value of Interactome3D is illustrated through the structural annotation of the complement cascade pathway, rationalizing a potential common mechanism of action suggested for several disease-causing mutations.